Status:

COMPLETED

Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Lead Sponsor:

Brugmann University Hospital

Conditions:

Cerebral Lesion

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are ...

Eligibility Criteria

Inclusion

  • Patients of the CHU Brugmann Hospital
  • Central neurological pathology of vascular or traumatic origin, acute or chronic (known since more than one year).

Exclusion

  • Pregnant or lactating women
  • Presence or antecedents of psychiatric disease
  • Degenerative pathology (ex: Parkinson...)
  • Antecedents of other neurologic pathologies before the acquired lesion
  • Oral or written comprehension dysfunctions.

Key Trial Info

Start Date :

April 9 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 28 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04034875

Start Date

April 9 2019

End Date

July 28 2023

Last Update

May 9 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Brugmann University Hospital

Brussels, Belgium, 1020

2

Hôpital Universitaire Pitié-Salpêtrière

Paris, France

3

Hôpitaux Saint Maurice

Saint-Maurice, France